The failure of earlier studies to detect a chemopreventive effect of aspirin may be due, in part, to the need for prolonged follow-up as studies reporting no reduction in CRC incidence initially (11, 15, 16) often noticed an effect after a longer interval ranging from 56 months to around 17 years